Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1383 studies found for:    Open Studies | "Genital Diseases, Female"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
Conditions: Hysterectomy;   Genital Diseases, Female;   Pain
Interventions: Behavioral: Follow-up strategy;   Behavioral: No contact after discharge
2 Recruiting Effect of Salpingectomy During Conservative Hysterectomy
Conditions: Genital Diseases, Female;   Hysterotomy; Affecting Fetus;   Leiomyomata Uteri;   Adenomyosis, Endometriosis;   Dysfunctional Uterine Bleeding;   Cervical Dysplasia;   Uterine Prolapse
Interventions: Procedure: conservative hysterectomy I;   Procedure: Conservative hysterectomy II
3 Not yet recruiting Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy
Condition: Genital Diseases, Female
Interventions: Device: Guardix-FL;   Device: Interceed
4 Recruiting Prognostic Markers of Gynecologic Cancers
Conditions: Gynecologic Disease;   Gynecologic Cancer
Intervention:
5 Not yet recruiting Comparison of Two Ventilation Modes With Laryngeal Mask Airway Guardian
Condition: Gynecologic Disease
Interventions: Procedure: tidal volume;   Procedure: peak airway pressure
6 Recruiting Biomarkers for Gynecologic Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Benign Gynecological Disease
Intervention:
7 Recruiting Preoperative Warm-up in Gynecologic Surgery
Condition: Gynecologic Disorders
Intervention: Other: Preoperative Warm-Up training
8 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
9 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
10 Unknown  Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Conditions: Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer;   Choriocarcinoma;   Uterine Fibroids;   Endometriosis
Intervention:
11 Recruiting Mechanism of Incontinence Before and After Genital Prolapse Surgery
Condition: Genital Prolapse
Intervention:
12 Recruiting Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.
Condition: Infertility
Interventions: Drug: Ganirelix 0.25 mg.;   Drug: Recombinant choriogonadotropin alfa;   Drug: Micronized natural progesterone.
13 Recruiting The Association of G9a Protein and the Outcome of Patients With Cervical Cancer
Condition: Cervical Cancer
Intervention:
14 Recruiting Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Brenner Tumor;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Stage II Ovarian Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Biological: Bevacizumab;   Drug: Veliparib;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis
15 Recruiting High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.
Condition: Cervical Cancer
Intervention: Radiation: IMRT
16 Unknown  Progestin Treatment for Endometrial Stromal Cells in Adenomyosis
Condition: Endometriosis
Intervention:
17 Recruiting Turner Syndrome Prenatal Diagnosis Study
Condition: Turner Syndrome
Intervention:
18 Recruiting Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Condition: Recurrent Platinum-sensitive Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: PLD;   Biological: Bevacizumab
19 Recruiting Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Intervention: Procedure: Acute Normovolemic Hemodilution
20 Recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Brenner Tumor;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Docetaxel;   Drug: Carboplatin;   Biological: Bevacizumab;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years